Pfizer's Zoetis (ZTS) May be Largest IPO Since Facebook (FB)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Caribou Biosciences to halt CAR-T programs, explore sale
- Stryker names Spencer Stiles as CEO, Lobo moves to chair
- Francis Halzen wins Nobel physics prize for Antarctic 'ghost particle' hunt
Zoetis (ZTS) Prices 86.1M IPO at $26/Share, Above Expected Range
February 1, 2013 6:53 AM ESTZoetis (NYSE: ZTS), formerly the animal health business unit of Pfizer Inc. (NYSE: PFE, announced the pricing of its initial public offering of 86,100,000 shares of its Class A common stock at $26 per share. The shares are expected to begin trading tomorrow, Feb. 1, on the New York Stock Exchange under the symbol... More
Pfizer's Zoeti (ZTS) IPO Prices at $26, Above Expected Range
January 31, 2013 5:47 PM ESTPfizer's (NYSE: PFE) animal health spin-off, Zoetis, Inc. (NYSE: ZTS), priced its IPO at $26 per share, above the expected $22-$25 range.
Shares are expected to being trading on the NYSE Friday under the symbol "ZTS."
The offering is being led by... More
Pfizer's Zoetis (ZTS) Sees IPO Price of $22 - $25/Share
January 17, 2013 5:11 PM ESTZoetis Inc. (NYSE: ZTS) filed an amended registration with the U.S. SEC for an Initial Public Offering of its Common Stock. The... More



